Clarus Lifesciences III, L.P. - May 11, 2021 Form 4 Insider Report for Talaris Therapeutics, Inc. (TALS)

Role
10%+ Owner
Signature
CLARUS LIFESCIENCES III, L.P., By: Clarus Ventures III GP, L.P., its GP, By: Blackstone Clarus III, L.L.C., its GP, By: Blackstone Holdings II L.P., its managing member, By: Blackstone Holdings I/II GP L.L.C., its GP, By: /s/ Tabea Hsi, SMD
Stock symbol
TALS
Transactions as of
May 11, 2021
Transactions value $
$510,000
Form type
4
Date filed
5/14/2021, 06:15 AM
Next filing
May 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TALS Common Stock Conversion of derivative security +4.86M 4.86M May 11, 2021 See Footnotes F1, F2, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +690K 690K May 11, 2021 See Footnotes F1, F3, F9, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +276K 276K May 11, 2021 See Footnotes F1, F4, F9, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +558K 558K May 11, 2021 See Footnotes F1, F5, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +363K 363K May 11, 2021 See Footnotes F1, F6, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +670K 670K May 11, 2021 See Footnotes F1, F7, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +134K 134K May 11, 2021 See Footnotes F1, F8, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +130K +18.87% 820K May 11, 2021 See Footnotes F1, F3, F9, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +52.1K +18.87% 328K May 11, 2021 See Footnotes F1, F4, F9, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +105K +18.87% 663K May 11, 2021 See Footnotes F1, F5, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +68.6K +18.87% 432K May 11, 2021 See Footnotes F1, F6, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +126K +18.87% 797K May 11, 2021 See Footnotes F1, F7, F10, F11, F12, F13, F14
transaction TALS Common Stock Conversion of derivative security +25.3K +18.87% 159K May 11, 2021 See Footnotes F1, F8, F10, F11, F12, F13, F14
transaction TALS Common Stock Purchase $271K +15.9K +0.33% $17.00* 4.88M May 11, 2021 See Footnotes F2, F11, F12, F13, F14
transaction TALS Common Stock Purchase $61.4K +3.61K +0.44% $17.00* 824K May 11, 2021 See Footnotes F3, F9, F11, F12, F13, F14
transaction TALS Common Stock Purchase $24.5K +1.44K +0.44% $17.00* 330K May 11, 2021 See Footnotes F4, F9, F11, F12, F13, F14
transaction TALS Common Stock Purchase $49.6K +2.92K +0.44% $17.00* 666K May 11, 2021 See Footnotes F5, F10, F11, F12, F13, F14
transaction TALS Common Stock Purchase $32.3K +1.9K +0.44% $17.00* 434K May 11, 2021 See Footnotes F6, F10, F11, F12, F13, F14
transaction TALS Common Stock Purchase $59.6K +3.51K +0.44% $17.00* 800K May 11, 2021 See Footnotes F7, F10, F11, F12, F13, F14
transaction TALS Common Stock Purchase $11.9K +701 +0.44% $17.00* 160K May 11, 2021 See Footnotes F8, F10, F11, F12, F13, F14

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TALS Series A Convertible Preferred Stock Conversion of derivative security -26M -100% 0 May 11, 2021 Common Stock 4.86M See Footnotes F1, F2, F11, F12, F13, F14
transaction TALS Series A-1 Convertible Preferred Stock Conversion of derivative security -3.69M -100% 0 May 11, 2021 Common Stock 690K See Footnotes F1, F3, F9, F11, F12, F13, F14
transaction TALS Series A-1 Convertible Preferred Stock Conversion of derivative security -1.48M -100% 0 May 11, 2021 Common Stock 276K See Footnotes F1, F4, F9, F11, F12, F13, F14
transaction TALS Series A-1 Convertible Preferred Stock Conversion of derivative security -2.98M -100% 0 May 11, 2021 Common Stock 558K See Footnotes F1, F5, F10, F11, F12, F13, F14
transaction TALS Series A-1 Convertible Preferred Stock Conversion of derivative security -1.94M -100% 0 May 11, 2021 Common Stock 363K See Footnotes F1, F6, F10, F11, F12, F13, F14
transaction TALS Series A-1 Convertible Preferred Stock Conversion of derivative security -3.59M -100% 0 May 11, 2021 Common Stock 670K See Footnotes F1, F7, F10, F11, F12, F13, F14
transaction TALS Series A-1 Convertible Preferred Stock Conversion of derivative security -717K -100% 0 May 11, 2021 Common Stock 134K See Footnotes F1, F8, F10, F11, F12, F13, F14
transaction TALS Series B Convertible Preferred Stock Conversion of derivative security -697K -100% 0 May 11, 2021 Common Stock 130K See Footnotes F1, F3, F9, F11, F12, F13, F14
transaction TALS Series B Convertible Preferred Stock Conversion of derivative security -279K -100% 0 May 11, 2021 Common Stock 52.1K See Footnotes F1, F4, F9, F11, F12, F13, F14
transaction TALS Series B Convertible Preferred Stock Conversion of derivative security -563K -100% 0 May 11, 2021 Common Stock 105K See Footnotes F1, F5, F10, F11, F12, F13, F14
transaction TALS Series B Convertible Preferred Stock Conversion of derivative security -367K -100% 0 May 11, 2021 Common Stock 68.6K See Footnotes F1, F6, F10, F11, F12, F13, F14
transaction TALS Series B Convertible Preferred Stock Conversion of derivative security -677K -100% 0 May 11, 2021 Common Stock 126K See Footnotes F1, F7, F10, F11, F12, F13, F14
transaction TALS Series B Convertible Preferred Stock Conversion of derivative security -135K -100% 0 May 11, 2021 Common Stock 25.3K See Footnotes F1, F8, F10, F11, F12, F13, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Series A Convertible Preferred Stock, Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted on a 1-for-5.35 basis into common stock of the Issuer upon the closing of the Issuer's initial public offering.
F2 Reflects securities held directly by Clarus Lifesciences III, L.P. Clarus Ventures III GP, L.P. is the general partner of Clarus Lifesciences III, L.P. Blackstone Clarus III L.L.C. is the general partner of Clarus Ventures III GP, L.P. The sole member of Blackstone Clarus III L.L.C. is Blackstone Holdings II L.P.
F3 Reflects securities held directly by Clarus Defined Exit I, L.P.
F4 Reflects securities held directly by Clarus DE II, L.P.
F5 Reflects securities held directly by Clarus IV-A, L.P.
F6 Reflects securities held directly by Clarus IV-B, L.P.
F7 Reflects securities held directly by Clarus IV-C, L.P.
F8 Reflects securities held directly by Clarus IV-D, L.P.
F9 Clarus Ventures DE GP, L.P. is the general partner of each of Clarus Defined Exit I, L.P. and Clarus DE II, L.P. Blackstone Clarus DE L.L.C. is the general partner of Clarus Ventures DE GP, L.P. The sole member of Blackstone Clarus DE L.L.C. is Blackstone Holdings II L.P.
F10 Clarus IV GP, L.P. is the general partner of each of Clarus IV-A, L.P., Clarus IV-B, L.P., Clarus IV-C, L.P. and Clarus IV-D, L.P. Blackstone Clarus GP L.P. is the general partner of Clarus IV GP, L.P. Blackstone Clarus GP L.L.C. is the general partner of Blackstone Clarus GP L.P. The sole member of Blackstone Clarus GP L.L.C. is Blackstone Holdings I L.P.
F11 The general partner of each of Blackstone Holdings I L.P. and Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Series II preferred stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
F12 Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 3.
F13 Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
F14 Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.